4//SEC Filing
KASTEN BERNARD L 4
Accession 0001171843-12-003817
CIK 0001318641other
Filed
Oct 28, 8:00 PM ET
Accepted
Oct 29, 6:05 PM ET
Size
5.1 KB
Accession
0001171843-12-003817
Insider Transaction Report
Form 4
KASTEN BERNARD L
Director
Transactions
- Award
Stock Options (Right to Buy)
2012-10-25+100,000→ 100,000 totalExercise: $1.45→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]100% of the stock options shall vest on December 31, 2012 if certain goals are achieved prior to such time. If such goals are not satisfied as of December 31, 2012, the options will not vest and will expire on December 31, 2012. If such goals are satisfied as of December 31, 2012, the options will vest and will expire on August 13, 2022.
Issuer
CLEVELAND BIOLABS INC
CIK 0001318641
Entity typeother
Related Parties
1- filerCIK 0001244745
Filing Metadata
- Form type
- 4
- Filed
- Oct 28, 8:00 PM ET
- Accepted
- Oct 29, 6:05 PM ET
- Size
- 5.1 KB